- -
Lecture on the theme of AI drug discovery at the 143rd Annual Meeting of the Pharmaceutical Society of Japan
FRONTEO Inc.
Masahiro Morimoto, President and CEO
2-12-23 Konan, Minato-ku, Tokyo
(Code number: 2158 TSE Growth)
At the "New Technology / New Product Seminar" exhibition held in conjunction with the 2023rd Annual Meeting of the Pharmaceutical Society of Japan to be held from March 3 (Sat) to 25 (Tue), 28, "FRONTEO's natural language AI realizes AI I will give a lecture on the theme of “Possibility of drug discovery”.
[Seminar Outline]
Theme: Possibility of AI drug discovery realized by FRONTEO's natural language AI
Contents: Made possible by our proprietary natural language AI solution
Introducing the acceleration of drug discovery research and the fulfillment and enhancement of new themes
Day and time: March 2023, 3 (Monday) 27:15-15:15
Venue:Hokkaido University seminar venue (in the exhibition hall)
Speakers: Nobuya Nakano (General Manager, Life Science AI Business Headquarters, FRONTEO Inc.)
annual meeting website : https://confit.atlas.jp/guide/event/pharm143/top
New Technology/New Product Seminar Program : https://www.nyk.gr.jp/info/143semi.pdf
*Registration to the academic meeting is required to participate in this seminar.